Remifentanil/Sufentanil for CABG+/-AVR Evaluated by Recovery, Cognitive Function, Haemodynamics and Biochemical Markers.
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the effect on cognitive function, recovery, cardioprotection and haemodynamics of
standard Remifentanil anaesthesia to standard Sufentanil anaesthesia in patients undergoing
coronary artery bypass with or without aortic valve replacement.